HomeUSA2Flo Ventures Adds Charlotte Jones-Burton as Partner

2Flo Ventures Adds Charlotte Jones-Burton as Partner

Charlotte Jones-Burton
Charlotte Jones-Burton MD, MS

2Flo Ventures, a Chicago, IL-based venture capital firm and startup studio focused on the discovery, development, and commercialization of healthcare solutions that address disparities in outcomes and health equity broadly, added Dr. Charlotte Jones-Burton as a Partner and Head of Life Science Product Development and Strategy.

Dr. Jones-Burton brings to the firm nearly two decades of experience in the biopharmaceutical industry leading clinical development of multiple medicines across various therapeutic areas. At Chinook Therapeutics, she advanced the pipeline as Senior VP of Product Development and Strategy, leading to a $3.2 Billion acquisition by Novartis. Previously, she was VP of Global Clinical Development and Head of Nephrology at Otsuka Pharmaceuticals. She founded and presides over Women of Color in Pharma (WOCIP®), advancing health equity and transforming the biopharmaceutical landscape for women of color. She holds a Doctor of Medicine (MD) and a Master of Science (MS) in epidemiology and preventive medicine, both awarded by the University of Maryland School

2Flo Ventures is an early-stage venture capital firm and startup studio. The firm has invested in nine nationally recognized companies employing 100+ people and have collectively raised over 85 million dollars. They build and invest in companies across biotechnology, medical devices, and digital health with a core mission of advancing health equity and addressing large unmet medical needs.